Safety of Daptomycin in Patients Receiving Hemodialysis

Study Objective. To determine the safety of daptomycin administered using a variety of doses and dosing frequencies in patients receiving intermittent hemodialysis who had probable or confirmed gram‐positive infections. Design. Analysis of data from the Cubicin Outcomes Registry and Experience (CORE...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacotherapy 2011-07, Vol.31 (7), p.665-672
Hauptverfasser:	Mueller, Bruce A., Crompton, Jason A., Donovan, Brian J., Yankalev, Sara, Lamp, Kenneth C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use antibiotics Biological and medical sciences Creatine Kinase - blood Creatine Kinase - drug effects daptomycin Daptomycin - administration & dosage Daptomycin - adverse effects Daptomycin - therapeutic use Dose-Response Relationship, Drug Drug Administration Schedule Emergency and intensive care: renal failure. Dialysis management Female Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - microbiology gram-positive infection hemodialysis Hospitals, Teaching Humans Intensive care medicine Male Medical sciences Middle Aged Pharmacology. Drug treatments Registries Renal Dialysis Retrospective Studies Staphylococcus aureus vancomycin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!